Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC

Access Activity

Overview / Abstract:

This interactive digital activity combines animated slides and expert video commentary on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence to enhance the implementation of precision medicine in the care of patients with EGFR-mutant NSCLC. Through this education, learners explore best practices for EGFR mutation testing, application of clinical trial data to treatment selection, and the role of concurrent mutations in the prognosis and response to therapy of patients with EGFR-mutant NSCLC.

Expiration

Dec 30, 2022

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

1.25

Accreditation

ACCME, ABPath MOC, MIPS QPP

Presenters / Authors / Faculty

Maria E. Arcila, MD
Attending Pathologist and Laboratory Director, Diagnostic Molecular Pathology
Medical Director, Molecular Hematopathology
Memorial Sloan Kettering Cancer Center
New York, NY

Justin Gainor, MD
Director, Center for Thoracic Cancers
Director of Targeted Immunotherapy
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Activity Specialities / Related Topics

Oncology / Cancer / Radiation Therapy, Pathology

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Lilly.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Lilly, justin gainor, maria arcila, pathology, oncology, EGFR-Mutant, EGFR, NSCLC, TP53, biomarker testing, multidisciplinary, Molecular Diagnostic Studies, genetic alteration, mutation, NCCN, targeted therapy, metastatic, histologic, liquid biopsy, tissue acquisition, Anaplastic lymphoma kinase, ALK, ROS proto-oncogene, TKI therapy, KRAS mutation, Neurotrophic Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map